Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ONCO3.SA
Strong SellOncoclínicas do Brasil Serviços Médicos S.A. · Healthcare · Brazil · $382M · Avg Vol: $7M/d
5
StockRankGet insider-trade alerts
Q
20
V
28
M
24
P/E (TTM)
—
ROE
-273.5%
D/E
39.5x
Dividend %
—
COMPANY DESCRIPTION
Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.1B | 5.5B | 6.2B | 5.7B | 12.0% | 5.0B | 6.3B | 6.2B | 4.1% |
| EPS (BRL) | 0.04 | 0.19 | -1.05 | -4.18 | 388.7% | -5.19 | — | — | — |
| Shares | 1.1B | 1.1B | 632.8M | 1.1B | -0.4% | 1.1B | — | — | — |
| Debt | 3.5B | 4.6B | 5.5B | 3.8B | 3.0% | 3.9B | — | — | — |
| Equity | 2.1B | 2.3B | 3.1B | 900.9M | -24.8% | — | — | — | — |
| Op CF | -271.6M | -51.6M | -184.9M | -118.6M | — | 313.1M | — | — | — |
| Inv CF | -408.7M | 227.8M | -1.7B | 793.0M | — | — | — | — | — |
| Fin CF | 407.1M | 111.4M | 1.9B | -712.2M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+82.4%
SMA 50SMA 200
Close
$0.2382
RSI (14)
64.7
52W High
$0.7506
From 52W High
0.3%
SCORE BREAKDOWN
Quality
20
ROIC
-150.1%4.4
ROE
-273.5%3.1
GP/Assets
19.1%44.8
Op. Margin
-27.7%24.7
FCF/Assets
-5.9%34.5
Piotroski
316.6
Int. Cover
-4.7x28.9
D/E Ratio
39.49x0.2
Current Ratio
0.44x2.2
Value
28
P/E (TTM)
—N/A
EV/EBITDA
-3.2x25.0
P/FCF
—N/A
P/B
137.1x0.5
P/S
0.4x93.5
Div Yield
—N/A
Momentum
24
52W High %
32%8.5
RS 6M
-46%16.9
SMA 50/200
0.57x4.0
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+102%75.0
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$382M
P/E (Forward)
24.4x
Gross Margin
27.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ONCO3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A.(you) | $382M | 5 | Strong Sell |
| MATD3.SA | Hospital Mater Dei S.A. | $328M | 96 | Strong Buy |
| BIOM3.SA | Biomm S.A. | $180M | 42 | Hold |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $15.3B | 83 | Strong Buy |
| DASA3.SA | Diagnósticos da América S.A. | $636M | 57 | Hold |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $490M | 74 | Buy |
| BLAU3.SA | Blau Farmacêutica S.A. | $415M | 84 | Strong Buy |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $353M | 93 | Strong Buy |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $261M | 98 | Strong Buy |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | $179M | 97 | Strong Buy |
Peer medians: ROE 10.6% · P/E 12.8x · Gross margin 31.0%